{"id":642,"date":"2016-03-01T13:24:47","date_gmt":"2016-03-01T12:24:47","guid":{"rendered":"http:\/\/ibtherapeutics.com\/?page_id=642"},"modified":"2023-10-02T15:04:55","modified_gmt":"2023-10-02T13:04:55","slug":"press-releases","status":"publish","type":"page","link":"https:\/\/ibtherapeutics.com\/sv\/investerare\/press-releases\/","title":{"rendered":"Pressmeddelanden"},"content":{"rendered":"<div class=\"mfn-newsfeed\"><form method=\"GET\" id=\"mfn-filter-form\"><div class=\"mfn-filter-container\"><div class=\"mfn-newsfeed-category-selector\"><script>\n                    function filterByCategory(e)\n                    {\n                        var type = e.getAttribute(\"filtertype\");\n                        var instance_id = document.getElementById(\"instance_id\").value;\n                        var q = document.getElementById(\"current_category_query\").value;\n                        if (type === \"dropdown\") {\n                            var el = document.getElementById(\"mfn-category-filter-\"  + instance_id);\n                            if (e.value !== \"\") q += \"&m-tags=\" + e.value;\n                            el.value = document.getElementById(\"category_tag\").value;\n                        } else if (type === \"buttons\") {\n                            if (e.value !== \"\") q += \"&m-tags=\" + e.value;\n                        }\n                        window.location.href = q;\n                        return false;\n                    }\n                 <\/script>\n                 <label for=\"mfn-category-filter-470887118\" class=\"mfn-category-label\">Category<\/label><select name=\"mfn-category-filter\" id=\"mfn-category-filter-470887118\" class=\"mfn-category-filter\" filtertype=\"dropdown\" onchange=\"filterByCategory(this);\">  <option value=\"\" selected>All<\/option>  <option value=\"regulatory\" >Regulatory<\/option>  <option value=\"-regulatory\" >Non-Regulatory<\/option> <\/select>  <input type=\"hidden\" id=\"current_category_query\" value=\"?\" \/>  <input type=\"hidden\" id=\"category_tag\" value=\"\" \/><\/div><div class='mfn-newsfeed-year-selector'><script>\n                        function filterByYear(e)\n                        {                           \n                        var q = document.getElementById(\"current_year_query\").value;\n                        var instance_id = document.getElementById(\"instance_id\").value;\n                        var el = document.getElementById(\"mfn-year-filter-\"  + instance_id);\n                        if (e.value !== \"\") q += \"&m-year=\" + e.value;\n                            el.value = document.getElementById(\"current_year\").value;\n                            window.location.href = q;\n                            return false;\n                        }\n                     <\/script>\n                     <label for=\"mfn-year-filter-470887118\" class=\"mfn-year-label\">Year<\/label><select name=\"mfn-year-filter\" id=\"mfn-year-filter-470887118\" class=\"mfn-year-filter\" onchange=\"filterByYear(this);\"><option url=\"?\" value=\"\">All<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2026\" value=\"2026\" >2026<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2025\" value=\"2025\" >2025<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2024\" value=\"2024\" >2024<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2023\" value=\"2023\" >2023<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2022\" value=\"2022\" >2022<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2021\" value=\"2021\" >2021<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2020\" value=\"2020\" >2020<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2019\" value=\"2019\" >2019<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2018\" value=\"2018\" >2018<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2017\" value=\"2017\" >2017<\/option><option url=\"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-year=2016\" value=\"2016\" >2016<\/option><\/select>  <input type=\"hidden\" id=\"current_year_query\" value=\"?\" \/>  <input type=\"hidden\" id=\"current_year\" value=\"\" \/><\/div><\/div>  <input type=\"hidden\" id=\"instance_id\" value=\"470887118\" \/><\/form><div class=\"mfn-list\">\n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-04-02 09:15<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/rattelse-kallelse-till-arsstamma-i-infant-bacterial-therapeutics\/'>R\u00e4ttelse: Kallelse till \u00e5rsst\u00e4mma i Infant Bacterial Therapeutics<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Infant Bacterial Therapeutics AB (publ) offentliggjorde den 30 mars 2026 en kallelse till &aring;rsst&auml;mman den 7 maj 2026. F&ouml;ljande &auml;r en<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-03-30 14:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/kallelse-till-arsstamma-i-infant-bacterial-therapeutics-10\/'>Kallelse till \u00e5rsst\u00e4mma i Infant Bacterial Therapeutics<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Infant Bacterial Therapeutics AB (publ), org.nr 556873-8586, med s&auml;te i Stockholm, kallar till &aring;rsst&auml;mma den 7 maj 2026 kl. 16.00 p&aring<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-03-27 07:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ab-publicerar-arsredovisning-for-2025\/'>Infant Bacterial Therapeutics AB publicerar \u00c5rsredovisning f\u00f6r 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>&Aring;rsredovisningen inklusive Bolagsstyrningsrapport f&ouml;r 2025 finns tillg&auml;nglig p&aring; IBT:s hemsida, www.ibtherapeutics.com under avsnitt<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-03-03 07:00<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ibt-publicerar-resultat-fran-the-connection-study-i-pediatric-research\/'>Infant Bacterial Therapeutics (IBT) publicerar resultat fr\u00e5n \u201cThe Connection Study\u201d i Pediatric Research<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>IBT har gl&auml;djen att meddela att resultaten fr&aring;n den avg&ouml;rande fas III-studien med IBP-9414 hos sp&auml;dbarn med mycket l&aring;g f&ouml;delsevikt<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2026-02-06 07:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ab-publ-bokslutskommunike-1-januari-31-december-2025\/'>Infant Bacterial Therapeutics AB (publ) Bokslutskommunik\u00e9 1 januari \u2013 31 december 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>VD Kommentarer IBTs plan att ans&ouml;ka om ett marknadsgodk&auml;nnande i USA genom en s&aring; kallad accelererad ans&ouml;kan kvarst&aring;r. Utvecklingsprogrammet<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-12-11 18:05<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ingar-partnerskap-med-bioconnection-for-produktion-av-lakemedel\/'>Infant Bacterial Therapeutics ing\u00e5r partnerskap med BioConnection f\u00f6r produktion av l\u00e4kemedel<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Infant Bacterial Therapeutics AB (IBT), vars mission &auml;r att utveckla och kommersialisera l&auml;kemedel f&ouml;r sjukdomar som drabbar f&ouml;r tidigt<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-11-25 18:41<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/ibt-byter-vag-for-marknadsgodkannande-for-ibp-9414-efter-diskussioner-med-fda\/'>IBT byter v\u00e4g f\u00f6r marknadsgodk\u00e4nnande f\u00f6r IBP-9414 efter diskussioner med FDA<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        \n            <span class='mfn-tag mfn-tag-mfn-regulatory-mar'>MAR<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Efter dagens m&ouml;te med FDA ang&aring;ende IBT:s levande bioterapeutiska produkt har IBT beslutat att g&aring; vidare med en accelererad godk&auml;nnandeprocess<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-11-20 16:42<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ab-sakerstaller-partnerskap-med-recipharm-advanced-bio-for-produktion-av-lakemedelssubstans\/'>Infant Bacterial Therapeutics AB s\u00e4kerst\u00e4ller partnerskap med Recipharm Advanced Bio f\u00f6r produktion av l\u00e4kemedelssubstans<\/a>\n                    <\/span>\n                    <span class='mfn-tags'><\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>Infant Bacterial Therapeutics AB (IBT) och Recipharm Advanced Bio, en del av Recipharm och en ledande kontraktsutvecklings- och tillverkningsorganisation<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-11-13 07:30<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ab-publ-delarsrapport-1-januari-30-september-2025\/'>Infant Bacterial Therapeutics AB (publ) Del\u00e5rsrapport 1 januari \u2013 30 september 2025<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>VD Kommentarer Risken f&ouml;r att d&ouml; minskade med 27% f&ouml;r de barn som f&aring;tt v&aring;r l&auml;kemedelskandidat IBP-9414 j&auml;mf&ouml;rt<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        \n            <div class='mfn-item'>\n                <div class='mfn-item-header'>\n                    <span class='mfn-date'>2025-10-20 10:35<\/span>\n                    <span class='mfn-title'>\n                        <a href='https:\/\/ibtherapeutics.com\/sv\/pressmeddelanden\/infant-bacterial-therapeutics-ab-publ-meddelar-att-valberedningen-infor-arsstamman-2026-bildats\/'>Infant Bacterial Therapeutics AB (publ) meddelar att valberedningen inf\u00f6r \u00e5rsst\u00e4mman 2026 bildats<\/a>\n                    <\/span>\n                    <span class='mfn-tags'>\n            <span class='mfn-tag mfn-tag-mfn-regulatory'>Regulatory<\/span>\n        <\/span>\n                <\/div>     \n        \n                <div class='mfn-item-body'>\n                    <div class='mfn-preview'>&Aring;rsst&auml;mman 2025 beslutade att styrelsens ordf&ouml;rande ska sammankalla de tre till r&ouml;stetalet st&ouml;rsta aktie&auml;garna i bolaget<span class=\"mfn-ellipsis\">...<\/span><\/div>\n                <\/div>\n            <\/div>        \n        <\/div><div class='mfn-newsfeed-pagination'><a href='https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642?m-page=1' class='mfn-page-link mfn-page-link-next'>Next<\/a><\/div><\/div>\n\n\n\n<h1 class=\"wp-block-heading\">Prenumerera p\u00e5 v\u00e5ra pressmeddelanden<\/h1>\n\n\n<div class=\"widget widget_mfn_subscription_widget\">\n            <script>        \n                if(!window._MF) {\n                    let b = document.createElement(\"script\");\n                    b.type = \"text\/javascript\";\n                    b.async = true;\n                    b.src =  \"https:\/\/widget.datablocks.se\/api\/rose\/assets\/js\/loader-v4.js\";\n                    document.getElementsByTagName(\"body\")[0].appendChild(b);\n    \n                    window._MF = window._MF || {\n                        data: [],\n                        url: \"https:\/\/widget.datablocks.se\/api\/rose\",\n                        ready: !!0,\n                        render: function() {\n                            window._MF.ready = !0\n                        },\n                        push: function(conf) {\n                            this.data.push(conf);\n                        }\n                    }\n                }\n                window._MF.push({\"query\":\"#subscribe-v2-wrapper-1449615946\",\"widget\":\"subscribe-v2\",\"token\":\"73fff0f4-6767-4ea4-8a09-f4f03fc4fce2\",\"locale\":\"sv\"})\n            <\/script>\n            <div id=\"subscribe-v2-wrapper-1449615946\" class=\"mfn-subscribe-v2\"><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Prenumerera p\u00e5 v\u00e5ra pressmeddelanden<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":622,"menu_order":45,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642"}],"collection":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/comments?post=642"}],"version-history":[{"count":8,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642\/revisions"}],"predecessor-version":[{"id":4092,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/642\/revisions\/4092"}],"up":[{"embeddable":true,"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/pages\/622"}],"wp:attachment":[{"href":"https:\/\/ibtherapeutics.com\/sv\/wp-json\/wp\/v2\/media?parent=642"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}